CAJ | 학술논문

目的评估自我管理干预(SMI)对改善Ⅲ型前列腺炎患者临床症状和生活质量的作用.方法2010年3月至2012年3月诊断为Ⅲ型前列腺炎的患者218例,随机分为SMI组和对照组.对照组108例,给予常规治疗;SMI组110例,常规治疗配合SMI.在治疗前和治疗后2周、4周、8周、12周、24周时,采用美国国立卫生研究院慢性前列腺炎症状指数评分(NIH-CPSI)对两组患者进行评价.结果两组患者均获随访.治疗前及治疗后第2周时SMI组疼痛不适(POD)分别为9.9±3.9和8.0±3.5,排尿症状(U)分别为5.8±3.3和4.7±2.7,生活质量(QoL)分别为9.2±2.0和7.6±1.7,总评分(TS)分别为25.0±6.7和20.3±5.9;对照组POD分别为9.9±4.2和9.4±4.1,U分别为6.3±2.9和5.5±2.6,QoL分别为8.9±2.1和8.6±2.1,TS分别为25.1±7.6和23.6±7.2,两组间比较差异均无统计学意义(P>0.05);第4周以后两组上述4项得分均持续下降,SMI组与治疗前得分相比差异均有统计学意义(P<0.01),而对照组除U得分差异有统计学意义外(P<0.01),其余3项得分均无显著性差异(P>0.05).治疗后第4周、8周、12周及24周时,SMI组的上述4项得分均低于对照组,差异均有统计学意义(P<0.01).结论采用SMI可明显减轻Ⅲ型前列腺炎患者的临床症状,提高生活质量.
목적평고자아관리간예(SMI)대개선Ⅲ형전렬선염환자림상증상화생활질량적작용.방법2010년3월지2012년3월진단위Ⅲ형전렬선염적환자218례,수궤분위SMI조화대조조.대조조108례,급여상규치료;SMI조110례,상규치료배합SMI.재치료전화치료후2주、4주、8주、12주、24주시,채용미국국립위생연구원만성전렬선염증상지수평분(NIH-CPSI)대량조환자진행평개.결과량조환자균획수방.치료전급치료후제2주시SMI조동통불괄(POD)분별위9.9±3.9화8.0±3.5,배뇨증상(U)분별위5.8±3.3화4.7±2.7,생활질량(QoL)분별위9.2±2.0화7.6±1.7,총평분(TS)분별위25.0±6.7화20.3±5.9;대조조POD분별위9.9±4.2화9.4±4.1,U분별위6.3±2.9화5.5±2.6,QoL분별위8.9±2.1화8.6±2.1,TS분별위25.1±7.6화23.6±7.2,량조간비교차이균무통계학의의(P>0.05);제4주이후량조상술4항득분균지속하강,SMI조여치료전득분상비차이균유통계학의의(P<0.01),이대조조제U득분차이유통계학의의외(P<0.01),기여3항득분균무현저성차이(P>0.05).치료후제4주、8주、12주급24주시,SMI조적상술4항득분균저우대조조,차이균유통계학의의(P<0.01).결론채용SMI가명현감경Ⅲ형전렬선염환자적림상증상,제고생활질량.
Objective To evaluate the effect of self-management intervention (SMI) on clinical symptoms and life quality of patients with type Ⅲ prostatitis (Ⅲp). Methods Two hundred and eighteen men diagnosed as Ⅲp from March 2010 to March 2012 were enrolled in the study and divided into two groups stochastically.Patients in the control group were given the conventional treatment and patients in the SMI group the conventional treatment plus self-management intervention. Scores of NIH-Chronic Prostatitis Symptom Index (NIH-CPSI) scale between the two groups were evaluated and comparatively analyzed at enrollment and the 2nd, 4th, 8th, 12th, 24th week of therapy. Results At enrollment and the 2nd week,the score of SMI group was pain or discomfort (POD) 9.9±3.9 and 8.0±3.5, urination(U) 5.8±3.3 and 4.7±2.7, quality of life(QoL) 9.2±2.0 and 7.6±1.7, total score(TS) 25.0±6.7 and 20.3±5.9, respectively; those of control group was POD 9.9±4.2 and 9.4±4.1, U 6.3 ±2.9 and 5.5±2.6, QoL 8.9±2.1 and 8.6±2.1, TS 25.1±7.6 and 23.6±7.2, accordingly. There was no statistic difference between the two groups(P>0.05). After 4th week, the scores of POD, U, QoL and TS Gradually decreased in the two groups,and compared to the scores at enrollment, all the tabular value difference have the significance (P<0.01)in SMI group,but only U value in control group. At the 4th, 8th, 12th and 24th week,the scores of POD, U, QoL and TS of SMI group were lower than those of the control group,and the tabular value difference to have the significance(P<0.01). Conclusion SMI is helpful to improve clinical symptoms and enhance life quality of Type Ⅲ prostatitis patients.